2.870EUR-0.69%Mkt Cap: 11.31M EURP/E: —Last update: 2026-06-01
Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a n…
Industry Peers
Diagnostics & Research183.26BUSDP/E 27.1
127.46BUSDP/E 35.0
45.09BUSDP/E 42.1
38.48BUSDP/E 27.4
37.00BUSDP/E 47.9
34.66BCHFP/E 38.1
31.51BUSD—
31.45BUSDP/E 23.4
Indicators:|
Key Statistics
Company
Market Cap11.31M EUR
Enterprise Value15.30M EUR
Revenue (TTM)728.08K EUR
Gross Profit604.24K EUR
Net Income (TTM)198.63M EUR
Revenue/Share0.1930 EUR
Last Price2.870 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees27
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-4.45
EV/Revenue21.01
P/S15.64
P/B-0.72
EPS (TTM)-1.06
EPS (Forward)—
52W Range
2.56022% of range4.000
52W High4.000 EUR
52W Low2.560 EUR
Profitability
Gross Margin97.76%
Oper. Margin-402.94%
EBITDA Margin0.00%
Profit Margin32137.35%
ROE-4653.75%
ROA8128.24%
Growth
Revenue Growth148.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.72M EUR
CapEx (TTM)5.39K EUR
FCF Margin-174.09%
FCF Yield-11.21%
Net Debt4.46M EUR
Net Debt/EBITDA-1.30
Balance Sheet
Debt/Equity-1.16
Current Ratio0.45
Quick Ratio0.43
Book Value/Sh-4.0020 EUR
Cash/Share0.1180 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.94M
Float—
Insiders69.05%
Institutions0.00%
Technical
SMA 503.011 (-4.7%)
SMA 2003.159 (-9.2%)
Beta0.26
S&P 52W Chg27.94%
Avg Vol (30d)643
Avg Vol (10d)736
Technical Indicators
RSI (14)48.6
MACD-0.0444
MACD Signal-0.0629
MACD Hist.+0.0185
BB Upper3.049 EUR
BB Middle2.857 EUR
BB Lower2.666 EUR
BB Width13.43%
ATR (14)0.1216 EUR
Vol Ratio (20d)0.58x